( June 11, 2026, 2:24 PM EDT) -- SEATTLE — Eli Lilly and Co., two medical centers and two of their physicians who prescribe patients compounded versions of tirzepatide XE "tirzepatide" , a U.S. Food and Drug Administration-approved drug for diabetes and weight loss, filed a joint notice that a sealed consent judgment and settlement agreement will be withdrawn after a Washington federal judge again refused to sign off on their agreement....